STRS Ohio’s Aldeyra Therapeutics ALDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$115K Hold
68,200
﹤0.01% 1720
2025
Q4
$353K Sell
68,200
-17,500
-20% -$89.9K ﹤0.01% 1246
2025
Q3
$447K Buy
85,700
+3,400
+4% +$17.7K ﹤0.01% 1154
2025
Q2
$315K Buy
82,300
+5,800
+8% +$15K ﹤0.01% 1493
2025
Q1
$440K Sell
76,500
-21,400
-22% -$127K ﹤0.01% 1259
2024
Q4
$489K Hold
97,900
﹤0.01% 1219
2024
Q3
$528K Buy
97,900
+6,200
+7% +$29.5K ﹤0.01% 1236
2024
Q2
$304K Buy
91,700
+9,400
+11% +$36.8K ﹤0.01% 1443
2024
Q1
$269K Sell
82,300
-5,200
-6% -$17.1K ﹤0.01% 1473
2023
Q4
$307K Buy
87,500
+63,900
+271% +$197K ﹤0.01% 1450
2023
Q3
$157K Hold
23,600
﹤0.01% 1630
2023
Q2
$198K Buy
+23,600
New +$233K ﹤0.01% 1589
2020
Q2
Sell
-29,700
Closed -$73K 2153
2020
Q1
$73K Hold
29,700
﹤0.01% 1729
2019
Q4
$172K Hold
29,700
﹤0.01% 1693
2019
Q3
$156K Sell
29,700
-42,200
-59% -$227K ﹤0.01% 1694
2019
Q2
$431K Buy
71,900
+5,000
+7% +$37.6K ﹤0.01% 1388
2019
Q1
$604K Buy
66,900
+28,100
+72% +$239K ﹤0.01% 1137
2018
Q4
$322K Buy
38,800
+34,100
+726% +$349K ﹤0.01% 1476
2018
Q3
$64K Hold
4,700
﹤0.01% 1917
2018
Q2
$37K Buy
+4,700
New +$37.5K ﹤0.01% 2016

Other funds holding ALDX

STRS Ohio's ALDX Position: Q1 2026 in Review

STRS Ohio held its Aldeyra Therapeutics (ALDX) position steady in Q1 2026 at 68,200 shares worth $115K. The position accounts for ﹤0.01% of the portfolio, ranked #1720.

STRS Ohio first reported a position in ALDX in Q2 2018 and has held it in 20 quarters since. The position peaked at $604K in Q1 2019. 126 funds tracked by Wall St. Rank hold ALDX as of Q1 2026.

  • STRS Ohio held 68,200 shares of Aldeyra Therapeutics worth $115K as of Q1 2026.
  • STRS Ohio left its Aldeyra Therapeutics share count unchanged in Q1 2026.
  • Aldeyra Therapeutics made up ﹤0.01% of STRS Ohio's portfolio in Q1 2026, its #1720 holding.
  • STRS Ohio first reported a position in Aldeyra Therapeutics in Q2 2018 and has held it in 20 quarters since.
  • STRS Ohio's Aldeyra Therapeutics position peaked at $604K in Q1 2019.
  • 126 funds tracked by Wall St. Rank held Aldeyra Therapeutics as of Q1 2026.

Based on STRS Ohio's 13F filing for Q1 2026, filed 24 Apr 2026.